mechanisms,23-27 binding affinity to agonists and antagonists,12'524 and inhibition of binding by dithiothreitol. 28, 29 Recently, two benzylimidazole derivatives, losartan (previously known as DuP 753) and PD123177, and the peptide CGP 42112A have been used to distinguish angiotensin II receptor subtypes in several tissues. 30 Losartan inhibits the AT, receptor, which is the predominant subtype in the adrenal cortex,29,31'32 vasculature,29 kidney,33 and liver,34 whereas PD123177 and CGP 42112A inhibit the AT2 receptor, present primarily in the adrenal medulla,31 uterus,29 ovary,35 brain,36 and the developing fetus. 37 The purpose of the present study was to determine the distribution, binding characteristics, and subtypes of the angiotensin II receptor in the rat heart by use of a quantitative in situ autoradiographic assay. In addition, because of the growth-snap-frozen in liquid nitrogen, and stored at -80C. Timed pregnant dams were housed under identical conditions and killed at a time corresponding to embryonic days 16 and 19 . The fetuses were removed and decapitated, and the hearts were excised quickly and frozen in liquid nitrogen. In separate experiments, pregnant dams were allowed to deliver and were housed together with their pups; thereafter, four pups were killed at postnatal days 1, 2, 3, and 10.
The distribution of cardiac angiotensin II receptors was assessed by a modification33 of the in situ receptor binding assay of Allen et al. 9 Briefly, tissue sections (10-20 gm) were cut on a cryostat at -20°C, thawmounted (two per slide) onto poly-L-lysine-coated slides, dried in vacuo for 18 hours at -4°to +4°C over silica gel, and stored in sealed Bakelite boxes at -80°C. Before the assay, the slides were brought to room temperature. A 4-cm2 square hydrophobic barrier was drawn around each tissue section with a PAP-pen (Kiyota International, Arlington, Ill. receptors, the effects of GTP-y-S on radioligand displacement was studied. Adjacent heart sections were preincubated for 15 minutes in buffer A, and total binding was measured after 15-120 minutes of incubation in the presence of 250 pM '251-[Sar ,11e8]angiotensin II together with either 10 luM PD123177 or 10 ,uM losartan to allow binding to AT1 or AT2 receptor subtypes, respectively. The reversibility of binding to the AT1 receptor was assessed by the addition, after 60 minutes of incubation, of either losartan (10 ,uM) or GTP-y-S (100 ,uM). The reversibility of binding to the AT2 receptor was assessed by the addition of either PD123177 (10 ,uM) or GTP-y-S (100 ,uM).
In the developmental study, the hearts were processed for emulsion autoradiography. Radioligand binding and receptor subtypes were quantified by counting the silver grains overlying the tissue. The values were compared with those of hearts taken from adult rats (10 and 14 weeks). To permit quantitative comparison, all the hearts used in this study were processed together.
Data are presented as mean+SEM. Comparisons were done by analysis of variance. Differences were considered to be statistically significant atp<5%. Figures 1C and 1D ). Quantification of the radioligand binding using emulsion autoradiography showed that losartan and PD123177 inhibited 50% and 53% of the specific binding, respectively 
Discussion
The results of this study demonstrate the presence of high-affinity angiotensin II receptors in the rat heart. Receptor density was similar in atria, right and left ventricles, and the intraventricular septum and was significantly greater in the atrioventricular node. Ligand binding was specific, saturable, and reversible. In addition to anatomic localization, the autoradiographic technique provided estimates of binding kinetics comparable to those obtained using cardiac membrane preparations from different animal species, including the rat.' '0 Analysis of equilibrium binding data using the inhibitors losartan and PD123177 suggests the presence of two classes of angiotensin receptors with a high affinity for the ligand.
Although the presence of two classes of cardiac angiotensin II receptors, one of high affinity and low capacity and the other with low affinity and high capacity, has been described previously.' 35 recently. 10 The presence of high affinity receptors in the myocardium can account for the positive inotropic effect of angiotensin in isolated muscle preparations of the mammalian heart.12-'6AAngiotensin II also has a positive chronotropic effect, but this may occur indirectly as a consequence of stimulation of cardiac efferent sympathetic activity40-42 and/or vagal inhibition.43-45 However, studies in cultured neonatal heart cells have provided strong evidence for a direct positive chronotropic effect that is blocked by specific angiotensin II antagonists46,47 and is not influenced by ,B-adrenergic blockade.15'8 The finding in the present and previous studies7,9"11 that angiotensin II binding to the specialized structures of the conduction system, and in particular to Incubations were carried out for 15-120 minutes. Total binding increased progressively during the first 60 minutes, reaching a plateau thereafter. Addition of both losartan and GTP-y-S at this point progressively displaced radioligand bound to the AT1 receptor subtype by 50% and 46% of the control value, respectively (both p<0.001). Addition of PD123177 progressively displaced radioligand bound to the AT2 receptor subtype by 43% of the control value (p<0. 001). Addition of GTP-y-S had no effect on displacement of radioligand bound to the AT2 receptor. Data are the mean +SEM ofsections obtainedfrom three 10-week-old rats. Experiments were performed in duplicate.
the atrioventricular node, is more abundant than binding in the surrounding myocardium further suggests a direct effect of angiotensin II on this structure. In the atrioventricular node, angiotensin II receptors may be located on the specialized conduction myocytes and/or on the neural endings innervating the conduction system, but the resolution obtained did not allow us to discriminate them. As yet, no physiological evidence 12.58 We have recently shown that the AT2 receptor is highly expressed in the mesenchymal tissue of the developing rat fetus and rapidly disappears after birth. 37 Similarly, it has been shown that during embryonic and immediate postnatal development rat aortic smooth muscle cells express AT2 receptors almost exclusively. 55 Conceivably, these findings could indicate a role for angiotensin II and AT2 receptors in tissue growth and development. In cultured chick heart cells, angiotensin II increases RNA and protein content,21,22 although the receptor subtype mediating this response has not been identified. In addition to these studies in isolated tissues, a role for angiotensin II in the development of cardiac hypertrophy in vivo is suggested by the observation that administration of converting enzyme inhibitors prevented or reversed hypertensive cardiac hypertrophy in both rats59 and humans.60 Moreover, treatment with doses of converting enzyme insufficient to reduce blood pressure61 or afterload62 still prevented or reversed hypertrophy in rats with aortic banding, indicating an effect of angiotensin II on the development of cardiac hypertrophy independent of systemic hemodynamics. Further studies using specific angiotensin II receptor antagonists will be required to determine which receptor subtype is involved in the hypertrophic response. In the present study, the findings that the density of angiotensin II receptors increased after birth and decreased toward prenatal values thereafter are in agreement with those of Urata and colleagues,7 who also found a postnatal decrease in rat ventricular angiotensin II binding sites. These observations indicate developmental regulation of angiotensin II receptors in the rat heart.
